←Back to Expert Scholars
Translational Medicine / 转化医学KRAS Inhibitors, Covalent Drug Design
Kenneth Westover
MD, PhD
🏢UT Southwestern Medical Center🌐USA
Associate Professor of Radiation Oncology
35
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Kenneth Westover contributed to early covalent KRAS G12C inhibitor design and continues structure-based discovery of pan-KRAS and G12D-selective compounds. His group integrates crystallography with medicinal chemistry. He is a clinician-scientist at UT Southwestern.
Share:
🧪Research Fields 研究领域
KRAS G12C
covalent inhibitors
structural biology
drug discovery
chemical biology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Kenneth Westover 的研究动态
Follow Kenneth Westover's research updates
留下邮箱，当我们发布与 Kenneth Westover（UT Southwestern Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment